Analysts predict Agilent
Technologies will report earnings of 72 cents per share on revenue of $1.24 billion.
is a global provider of life sciences, diagnostics, and applied chemical markets.
Once the acquisition is final, former YI Scientific customers of Agilent
products and related services in the South Korean market can look forward to an integrated sales and service portfolio directly from Agilent
Strong Positions in Competitive Markets: Agilent
holds leading positions in its largest markets, but several of its primary competitors have greater overall scale and financial flexibility than Agilent
, including Thermo Fisher Scientific Corp., Danaher Corp., Abbott Laboratories, and Roche.
Measurement Suite will be housed within Imperial's Molecular Sciences Research Hub at the new White City Campus due to open later this year.
had announced its intent on 27 June 2016 to acquire substantially all of the assets of iLab, including iLab's technology, intellectual property and product portfolio, as well as employee talent.
The China Food and Drug Administration has approved US-based Agilent
Technologies Inc.'s (NYSE: A) SureScan Dx microarray scanner as a medical device for in vitro diagnostic use.
The availability of Agilent
SurePrint human, mouse and rat miRNA microarrays, with miRBase 21 targets, provides pre-designed microarrays for the most commonly studied models.
The compliance test bench is available as an add-on to Advanced Design System 2014.01 software from Agilent
Technologies in collaboration with the company's regional partner Emitac organised the third Metrology Forum in Abu Dhabi on April 9 and 10.